Vetherapy® - Veterinary Regenerative Medicine
Vetherapy uses stem cells, PRP, and biomaterials to create effective veterinary regenerative medicine products.
Vetherapy uses stem cells, PRP, and biomaterials to create effective veterinary regenerative medicine products.
Vetherapy is a biotech startup founded in 2015 with its headquarters in the United States. The company focuses on Veterinary Regenerative Medicine, utilizing stem cells, platelet-rich plasma (PRP), and biomaterials to create effective therapeutic products for animals through Tissue Engineering. In January 2019, Vetherapy secured a €71.43K grant investment from EASME - EU Executive Agency for SMEs. This investment serves as a validation of Vetherapy's innovative approach to animal health and positions the company for further growth and development within the biotech industry. Vetherapy's focus on regenerative medicine presents an opportunity to address unmet medical needs in the veterinary space, potentially offering significant health benefits to animals. With the backing of the EU Executive Agency for SMEs, Vetherapy demonstrates the potential to make a meaningful impact in the field of veterinary medicine.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | €71.43K | 1 | EASME - EU Executive Agency for SMEs | 01 Jan 2019 |
| Seed Round | Unknown | 2 |
|
22 Jan 2018 |
No recent news or press coverage available for Vetherapy® - Veterinary Regenerative Medicine.
We care about your data, and we'd love to use cookies make your experience better.
